GSK3B and Alzheimer disease: Importantly, 18 AO targets that regulate tau phosphorylation are the core targets of AO in the treatment of AD, including AKT1, APP, CASP3, CCND1, GSK3B, MAPK1, MAPK3, and MAPT (Figure 5A).